Human Longevity Acquires Cypher Genomics | GenomeWeb

NEW YORK (GenomeWeb) – Human Longevity said today that it has acquired genome informatics firm Cypher Genomics for an undisclosed amount.

San Diego-based Cypher Genomics has been offering human genome interpretation software. The company's 14 employees will join Human Longevity, including CEO and cofounder Ashley Van Zeeland, who is now heading Human Longevity's pediatric business.

Cypher's Mantis software is used to interpret genomic sequencing data to find clinically significant variants. In addition, the company has developed a biomarker discovery service called Coral.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.